AivexaNewsSearch
AI news for builders and product teamsUpdated Nov 17, 2026, 14:00 UTC

AI news, straight from the source.

Releases, research, and ideas for developers and product teams. Updated every hour.

Across the feeds

Newest first

Build composable, interoperable multi-agent systems with A2A on AWS

AWS published a deployable reference architecture in which a LangChain-based enterprise orchestrator calls a Strands Agents-based compliance agent in a separate AWS account using the A2A protocol, deployed from three Jupyter notebooks. Each side has its own Amazon Cognito user pool and only public values are exchanged during onboarding, so no secrets are shared.

Read original

From prototype to production: Engineering agents with Agent DLC

AWS's Agent DLC proposes judging every LLM agent change against an approved "gold standard" of criteria, thresholds and examples, backed by repeated-run pass rates rather than single test assertions. A reference HR policy assistant showed chunk-level retrieval precision of 1.00 while fact-level precision fell to 0.09 on one question, hiding a missing-document problem.

Read original

Cyberattack on Fireworks AI allowed hackers to access Notion customers’ chat transcripts

Fireworks AI confirmed a cyberattack in which hackers breached its cloud provider, reached a Fireworks development system, and stole customer billing information and some datasets. Notion says chat transcripts from about 1% of its customers who used its Insights feature were taken; Fireworks says the attackers appear financially motivated, aiming to resell access to LLMs.

Read original

AI #194: Spy Versus Guy

Zvi Mowshowitz's weekly AI roundup covers Claude Fable 5.2's mixed debut, GPT-6 Cyber's Linux kernel security work (948 working exploits), Gemini 4 Carbon's release to Ultra and API users, and the timeline updates following METR's AI R&D acceleration report.

Read original

Google Deepmind shifts genomics AI from bulk tissue predictions to single cell type resolution with AlphaGenome 2

Google DeepMind released AlphaGenome 2, a genomics model that predicts variant effects for individual cell types rather than bulk tissue, trained on over 107 million cell profiles from 68 tissues. It found roughly twice as many disease-relevant variants as its predecessor and is available for noncommercial research via API, with a closed commercial preview.

Read original